Global /South Korea /Healthcare /Drug Manufacturers - General /001540

Ahn-Gook Pharmaceutical Co., Ltd.

001540

• KRX: 001540 • Delayed

8,170KRW -0.4%

5.35 USD

As of 13 June 2026, Ahn-Gook Pharmaceutical Co., Ltd. has a market cap of $61.06M USD, ranking #29118 globally and #1584 in South Korea. It ranks #2636 in the Healthcare sector, and #938 in the Drug Manufacturers - General industry.

Global Rank

29118

Country Rank

1584

Sector Rank

2636

Industry Rank

938

Key Stats

Market Cap

$61.06MUSD

92.86B KRW

Enterprise Value

$73.9MUSD

112.79B KRW

Revenue (TTM)

$201.78MUSD

306.87B KRW

EBITDA (TTM)

$12.17MUSD

18.58B KRW

Net Income (TTM)

$4.92MUSD

7.48B KRW

EBITDA Margin

6.1%

Profit Margin

2.4%

PE Ratio

12.4

PS Ratio

0.3

PB Ratio

0.6

EV/EBITDA

6.3

Company Profile

Country (HQ)

South Korea

Sector

Healthcare

Industry

Drug Manufacturers - General

Employees

391

Founded

1959

Website

ahn-gook.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-0.4%	-0.2%	2.3%	-3.1%	3.4%	-3.4%	22%	-3.9%	-39%

News

Markets

Exchange	Ticker	Price	Quotes
Korea Exchange (KRX) MIC: XKRX PRIMARY	001540 안국약품(주) ISIN: KR7001540004 Shares Out.: Shares Outstanding: 11.365M¹ Shares Float: 4.424M² TV: TradingView: KRX: 001540 SA: Stock Analysis: KRX: 001540 YF: Yahoo Finance: 001540.KS GF: Google Finance: KRX: 001540 BA: Barron's: 001540 MS: Morningstar: XKRX: 001540	8,170 KRW	TV: TradingView: KRX: 001540 SA: Stock Analysis: KRX: 001540 YF: Yahoo Finance: 001540.KS GF: Google Finance: KRX: 001540 BA: Barron's: 001540 MS: Morningstar: XKRX: 001540

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Ahn-Gook Pharmaceutical Co., Ltd.

Ahn-Gook Pharmaceutical Co., Ltd. manufactures and sells pharmaceutical products. The company's pharmaceutical products include Cinatura and Revo Tension. The company was founded in 1959 and is headquartered in Seoul, South Korea.

Similar Companies

Industry: Drug Manufacturers - General (South Korea)

Name	Market Cap (USD) diff.	PE	Country
Samsung Epis Holdings Co., Ltd. KRX: 0126Z0	$9.15B 13.91T KRW 15K%	-	South Korea
Sam Chun Dang Pharm. Co., Ltd. KRX: 000250	$6.77B 10.3T KRW 11K%	1958.1	South Korea
SK Biopharmaceuticals Co., Ltd. KRX: 326030	$5.24B 7.97T KRW 8K%	29.9	South Korea
ABL Bio Inc. KRX: 298380	$4.96B 7.55T KRW 8K%	-	South Korea
Yuhan Corp. KRX: 000100	$4.55B 6.92T KRW 7K%	35.9	South Korea
LigaChem Biosciences Inc. KRX: 141080	$4.44B 6.76T KRW 7K%	-	South Korea

Industry: Drug Manufacturers - General (Global)

Name	Market Cap (USD) diff.	PE	Country
Eli Lilly and Co. NYSE: LLY	$761.68B 1M%	38.1	United States
Johnson & Johnson NYSE: JNJ	$547.28B 896K%	26.4	United States
AbbVie Inc. NYSE: ABBV	$360.63B 591K%	97.4	United States
Roche Holding AG SIX: RO	$321.52B 256.25B CHF 526K%	19.9	Switzerland
AstraZeneca PLC LSE: AZN	$288.84B 215.59B GBP 473K%	27.6	United Kingdom
Novartis AG SIX: NOVN	$274.65B 218.9B CHF 450K%	20.5	Switzerland

chevron_leftBack